Q2 2023 Trend Reports – NPS Benzodiazepines, NPS Opioids, NPS Stimulants & Hallucinogens, and Synthetic Cannabinoids in the U.S. Posted on July 18, 2023July 18, 2023 By sdargoltz Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT CFSRE; July 2023 Access article Cannabis and Cannabinoids, Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Sexual Assault / SANE, Toxicology Tags:CFSRE